dokumendiregister.ee
OtsingAsutusedMCP
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel
Otsing›Ravimiamet
Sissetulev kiriAvalik

Inquiry

Ravimiamet · 2. juuli 2025
Viit
RST-1/3291-1
Registreeritud
2. juuli 2025
Dokumendi liik
Sissetulev kiri
Adressaat
SIA Merck Sharp & Dohme Latvija
Saabumis/saatmisviis
e-post
Funktsioon
RST Ravimistatistika tegemine
Sari
RST-1 Ravimistatistika alane kirjavahetus
Toimik
RST-1/2025
Vastutaja
Janne Sepp (RA, Peadirektori asetäitja valdkond, Ravimiohutuse osakond, Statistikabüroo)
Lahendamise tähtaeg
2. aprill 2025

Failid

  • 📎E-kiri.eml106 KB
  • 📎image001.png

Sisu (failidest)

Saatja: "Janne Sepp" <[email protected]> Saaja: "Kärolin Jenas" <[email protected]> Teema: Ed: MSD data request clarification Kuupäev: 2025-03-20 09:47 Saatja: Veips, Artūrs <[email protected]> Saatmisaeg: teisipäev, 18. märts 2025 12:34 Adressaat: Janne Sepp <[email protected]>; Dzirkale, Ieva <[email protected]> Koopia: Muursepp, Andres <[email protected]> Teema: MSD data request clarification Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Proprietary Hello Janne. I am new Data analyst for MSD Baltics, my colleague Andres Muursepp recommended that I get in touch with you regarding a report we recieve from you on quarterly basis called “EE Medicine Agency statistics”. Could you please clarify few aspects regarding the data and its availability. 1. Is it possible to recieve this data on monthly basis? Quarterly data while great, leaves a large period blank until we recieve the next report, therefore would be greatly appreciated if we recieved this information on monthly basis. 2. Is it possible to add a column in the reports that discloses to what institution exactly the products have been shipped as currently only totals for hospitals, pharmacies and others are visible. 3. Could you please provide guidance on the availability of data related to oncology, specifically concerning ICD-10 codes, and the associated costs for each treatment? If this should be adressed to someone else, please let me know. Best regards, Artūrs Veips Insight analyst Baltic region MSD A. Skanstes str. 50A, Riga, Latvia LV-1013 M. +371 28781254 <http://www.msd.lv/> www.msd.lv Today MSD is a global healthcare leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., Rahway, NJ., U.S.A. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.msd.com <http://www.msd.com>
Allikas: Ravimiamet dokumendiregister →